{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0167650?format=json",
    "@type": "researchers",
    "rm:user_id": "1000003035",
    "rm:creator_id": "1000003035",
    "rm:creator_type": "myself",
    "rm:created": "2009-03-09T15:00:00Z",
    "rm:modifier_id": "1000003035",
    "rm:modifier_type": "myself",
    "rm:modified": "2020-08-27T03:37:43Z",
    "permalink": "read0167650",
    "family_name": {
        "ja": "長内",
        "ja-Kana": "オサナイ",
        "en": "Osanai"
    },
    "given_name": {
        "ja": "智宏",
        "ja-Kana": "トモヒロ",
        "en": "Tomohiro"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "弘前大学",
                "en": "Hirosaki University"
            },
            "section": {
                "ja": "医学部 医学科",
                "en": "School of Medicine, Medicine"
            },
            "job": {
                "ja": "助教授・准教授",
                "en": "Associate Professor"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "0124001001"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "医学博士",
                "en": "(BLANK)"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "9999999999"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901055797640791"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901055797640791"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0167650/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0167650",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_interests/1015518",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_interests",
                    "rm:id": "1015518",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "keyword": {
                        "ja": "循環器内科"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_interests/1015517",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_interests",
                    "rm:id": "1015517",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "keyword": {
                        "en": "atherosclerosis"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_interests/1015516",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_interests",
                    "rm:id": "1015516",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "keyword": {
                        "en": "coronary spasm"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_interests/1015515",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_interests",
                    "rm:id": "1015515",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "keyword": {
                        "en": "hypertension"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0167650/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0167650",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_areas/424445",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_areas",
                    "rm:id": "424445",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A53020",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "循環器内科学",
                        "en": "Cardiology"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0167650/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0167650",
            "total_items": 54,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684108",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684108",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-31T16:53:14Z",
                    "paper_title": {
                        "en": "Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: a role of acidosis-induced c-Src activation"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Takashi Echizen"
                            },
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Toshihiro Ashitate"
                            },
                            {
                                "name": "Hiroaki Yokoyama"
                            },
                            {
                                "name": "Shuji Shibutani"
                            },
                            {
                                "name": "Makoto Tanaka"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Koji Magota"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Vascular endothelial growth factor (VEGF) is a well-known promoter of angiogenesis, but its receptor VEGFR-1 and a soluble short form of VEGFR-1 (sFlt-1) play a negative role in the VEGF signal pathway by trapping VEGF. We recently showed that endogenous prostacyclin inhibitor coupling factor 6 (CF6) forces the clockwise rotation of F1 motor of plasma membrane adenosine triphosphate synthase and induces intracellular acidosis and c-Src activation. We investigated the role of CF6 in regulation of sFlt-1, and its mechanism in human umbilical vein endothelial cells. The ratio of sFlt-1 to glyceraldehyde 3-phosphate dehydrogenase mRNA was increased at 24 h by 1.59 +/- 0.29-fold by 10(-7) M CF6 (P&lt;0.05), concomitantly with the increases in intercellular adhesion molecule-1 and lectin-like oxidized low-density lipoprotein receptor-1 and no change in VEGF-A. When the dose of CF6 was increased to 10(-6) M, no further increase in sFlt-1 mRNA was observed. The release of sFlt-1 protein was increased by 1.72 +/- 0.24-fold (P&lt;0.05) at 48 h after exposure to CF6 at 10(-7) M, and it was blocked by pretreatment with anti-CF6 antibody. The immunoreactive bands for sFlt-1 and VEGFR-1 were both increased by CF6 to similar degrees. Pretreatment with PP1, an inhibitor of c-Src, and 10(-5) M efrapeptin, an inhibitor of F1 motor, inhibited CF6-induced increases in expression and release of sFlt-1 (P&lt;0.05). In mice overexpressing CF6, the plasma level of sFlt-1 was increased by 1.36 +/- 0.29-fold compared with that in wild-type mice (P&lt;0.05). These indicate that CF6 might increase the expression and release of sFlt-1 in the vessels through acidosis-induced c-Src activation."
                    },
                    "publisher": {
                        "en": "NATURE PUBLISHING GROUP"
                    },
                    "publication_date": "2009-03",
                    "publication_name": {
                        "en": "HYPERTENSION RESEARCH"
                    },
                    "volume": "32",
                    "number": "3",
                    "starting_page": "182",
                    "ending_page": "187",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10024829936"
                        ],
                        "doi": [
                            "10.1038/hr.2008.24"
                        ],
                        "issn": [
                            "0916-9636"
                        ],
                        "pm_id": [
                            "19262480"
                        ],
                        "wos_id": [
                            "WOS:000264560400003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10024829936",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/hr.2008.24",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/19262480",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000264560400003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684107",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684107",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-29T11:47:00Z",
                    "paper_title": {
                        "en": "Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Motoi Kushibiki"
                            },
                            {
                                "name": "Masahiro Yamada"
                            },
                            {
                                "name": "Makoto Tanaka"
                            },
                            {
                                "name": "Toshihiro Ashitate"
                            },
                            {
                                "name": "Takashi Echizen"
                            },
                            {
                                "name": "Chisato Katoh"
                            },
                            {
                                "name": "Koji Magota"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Coupling factor 6 (CF6) induces hypertension by attenuating the endothelial generation of prostacyclin. However, intracellular signalling of CF6 in the resistance arteriole vascular smooth muscle cells (VSMCs) that are directly related to vasoconstriction has not been determined. Here we investigated the direct effect of exogenous CF6 on Ca(2+) signalling in cultured VSMCs and the in vivo role of endogenous CF6 in the genesis of hypertension using CF6 transgenic (TG) mice.\nCF6 induced a monophasic increase in the intracellular free Ca(2+) concentration ([Ca(2+)](i)) through nifedipine-sensitive Ca(2+) channels in A7r5 cells, a cell line of VSMCs, and enhanced the angiotensin II-induced spike phase of [Ca(2+)](i) to a greater degree in VSMCs derived from spontaneously hypertensive rats (SHRs). In the mesenteric arterioles obtained from CF6-TG mice that manifested hypertension, angiotensin II-induced vasoconstriction was enhanced, compared with wild-type mice, and its enhancement was abolished by an anti-CF6 antibody. Pre-treatment with PP1, a tyrosine kinase c-Src inhibitor, blocked CF6-induced increase in Ca(2+) signalling in VSMCs and vasoconstriction in TG mice. The receptor of CF6 was F(1) motor of adenosine triphosphate (ATP) synthase with a higher affinity in SHRs. CF6 decreased intracellular pH via activation of ATPase activity and led to c-Src activation to a greater degree in SHR-derived VSMCs.\nCF6 causes hypertension by directly enhancing Ca(2+) signalling in VSMCs and vasoconstriction in the mesenteric arteriolar network via c-Src activation."
                    },
                    "publisher": {
                        "en": "OXFORD UNIV PRESS"
                    },
                    "publication_date": "2009-03",
                    "publication_name": {
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "81",
                    "number": "4",
                    "starting_page": "780",
                    "ending_page": "787",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1093/cvr/cvn356"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000263407900020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1093/cvr/cvn356",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000263407900020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684087",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684087",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-31T16:53:14Z",
                    "paper_title": {
                        "en": "Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: a role of acidosis-induced c-Src activation"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Takashi Echizen"
                            },
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Toshihiro Ashitate"
                            },
                            {
                                "name": "Hiroaki Yokoyama"
                            },
                            {
                                "name": "Shuji Shibutani"
                            },
                            {
                                "name": "Makoto Tanaka"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Koji Magota"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Vascular endothelial growth factor (VEGF) is a well-known promoter of angiogenesis, but its receptor VEGFR-1 and a soluble short form of VEGFR-1 (sFlt-1) play a negative role in the VEGF signal pathway by trapping VEGF. We recently showed that endogenous prostacyclin inhibitor coupling factor 6 (CF6) forces the clockwise rotation of F1 motor of plasma membrane adenosine triphosphate synthase and induces intracellular acidosis and c-Src activation. We investigated the role of CF6 in regulation of sFlt-1, and its mechanism in human umbilical vein endothelial cells. The ratio of sFlt-1 to glyceraldehyde 3-phosphate dehydrogenase mRNA was increased at 24 h by 1.59 +/- 0.29-fold by 10(-7) M CF6 (P&lt;0.05), concomitantly with the increases in intercellular adhesion molecule-1 and lectin-like oxidized low-density lipoprotein receptor-1 and no change in VEGF-A. When the dose of CF6 was increased to 10(-6) M, no further increase in sFlt-1 mRNA was observed. The release of sFlt-1 protein was increased by 1.72 +/- 0.24-fold (P&lt;0.05) at 48 h after exposure to CF6 at 10(-7) M, and it was blocked by pretreatment with anti-CF6 antibody. The immunoreactive bands for sFlt-1 and VEGFR-1 were both increased by CF6 to similar degrees. Pretreatment with PP1, an inhibitor of c-Src, and 10(-5) M efrapeptin, an inhibitor of F1 motor, inhibited CF6-induced increases in expression and release of sFlt-1 (P&lt;0.05). In mice overexpressing CF6, the plasma level of sFlt-1 was increased by 1.36 +/- 0.29-fold compared with that in wild-type mice (P&lt;0.05). These indicate that CF6 might increase the expression and release of sFlt-1 in the vessels through acidosis-induced c-Src activation."
                    },
                    "publisher": {
                        "en": "NATURE PUBLISHING GROUP"
                    },
                    "publication_date": "2009-03",
                    "publication_name": {
                        "en": "HYPERTENSION RESEARCH"
                    },
                    "volume": "32",
                    "number": "3",
                    "starting_page": "182",
                    "ending_page": "187",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10024829936"
                        ],
                        "doi": [
                            "10.1038/hr.2008.24"
                        ],
                        "issn": [
                            "0916-9636"
                        ],
                        "pm_id": [
                            "19262480"
                        ],
                        "wos_id": [
                            "WOS:000264560400003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10024829936",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/hr.2008.24",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/19262480",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000264560400003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684086",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684086",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-29T11:47:00Z",
                    "paper_title": {
                        "en": "Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Motoi Kushibiki"
                            },
                            {
                                "name": "Masahiro Yamada"
                            },
                            {
                                "name": "Makoto Tanaka"
                            },
                            {
                                "name": "Toshihiro Ashitate"
                            },
                            {
                                "name": "Takashi Echizen"
                            },
                            {
                                "name": "Chisato Katoh"
                            },
                            {
                                "name": "Koji Magota"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Coupling factor 6 (CF6) induces hypertension by attenuating the endothelial generation of prostacyclin. However, intracellular signalling of CF6 in the resistance arteriole vascular smooth muscle cells (VSMCs) that are directly related to vasoconstriction has not been determined. Here we investigated the direct effect of exogenous CF6 on Ca(2+) signalling in cultured VSMCs and the in vivo role of endogenous CF6 in the genesis of hypertension using CF6 transgenic (TG) mice.\nCF6 induced a monophasic increase in the intracellular free Ca(2+) concentration ([Ca(2+)](i)) through nifedipine-sensitive Ca(2+) channels in A7r5 cells, a cell line of VSMCs, and enhanced the angiotensin II-induced spike phase of [Ca(2+)](i) to a greater degree in VSMCs derived from spontaneously hypertensive rats (SHRs). In the mesenteric arterioles obtained from CF6-TG mice that manifested hypertension, angiotensin II-induced vasoconstriction was enhanced, compared with wild-type mice, and its enhancement was abolished by an anti-CF6 antibody. Pre-treatment with PP1, a tyrosine kinase c-Src inhibitor, blocked CF6-induced increase in Ca(2+) signalling in VSMCs and vasoconstriction in TG mice. The receptor of CF6 was F(1) motor of adenosine triphosphate (ATP) synthase with a higher affinity in SHRs. CF6 decreased intracellular pH via activation of ATPase activity and led to c-Src activation to a greater degree in SHR-derived VSMCs.\nCF6 causes hypertension by directly enhancing Ca(2+) signalling in VSMCs and vasoconstriction in the mesenteric arteriolar network via c-Src activation."
                    },
                    "publisher": {
                        "en": "OXFORD UNIV PRESS"
                    },
                    "publication_date": "2009-03",
                    "publication_name": {
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "81",
                    "number": "4",
                    "starting_page": "780",
                    "ending_page": "787",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1093/cvr/cvn356"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000263407900020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1093/cvr/cvn356",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000263407900020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684105",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684105",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-08T23:35:06Z",
                    "paper_title": {
                        "en": "Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Akiko Kumagai"
                            },
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Chisato Katoh"
                            },
                            {
                                "name": "Makoto Tanaka"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Takeshi Morimoto"
                            },
                            {
                                "name": "Reiichi Murakami"
                            },
                            {
                                "name": "Koji Magota"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Coupling factor 6 (CF6), a component of ATP synthase, suppresses the generation of prostacyclin and nitric oxide (NO). Platelet endothelial cell adhesion molecule-1 (PECAM-1) is involved in shear-induced NO production. To investigate the linkage between the actions of CF6 and PECAM-1, we examined the effects of CF6 on PECAM-1 expression and shear-mediated NO release, comparatively with those of angiotensin II (AngII). Treatment of human umbilical vein endothelial cells (HUVEC) and aortic endothelial cells (HAEC) with CF6 at 10(-7) M or AngII at 10(-7) M for 24 h suppressed PECAM-1 gene and protein expression. CF6 or AngII activated c-Src at 15 min in HUVEC, and blockade of c-Src with PP1, its specific inhibitor, restored them. Efrapeptin, an inhibitor of ATPase, attenuated CF6-induced suppression of PECAM-1 gene expression by blockade of acidification, whereas superoxide dismutase or apocinin, an inhibitor of NADPH oxidase, blocked AngII-induced suppression of PECAM-1. Exposure of the cells to shear stress at 25 dynes/cm(2) for 30 min enhanced phosphorylation of eNOS at Ser(1177) and NO release. Pretreatment with CF6 or AngII for 24 h attenuated them in HUVEC and HAEC. These suggest that CF6 downregulates PECAM-1 expression via c-Src activation and attenuates shear-induced NO release presumably by suppressing eNOS phosphorylation. (C) 2007 Elsevier Ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2008-09",
                    "publication_name": {
                        "en": "ATHEROSCLEROSIS"
                    },
                    "volume": "200",
                    "number": "1",
                    "starting_page": "45",
                    "ending_page": "50",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.atherosclerosis.2007.12.010"
                        ],
                        "issn": [
                            "0021-9150"
                        ],
                        "wos_id": [
                            "WOS:000259549800005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.atherosclerosis.2007.12.010",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000259549800005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684085",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684085",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-08T23:35:06Z",
                    "paper_title": {
                        "en": "Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Akiko Kumagai"
                            },
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Chisato Katoh"
                            },
                            {
                                "name": "Makoto Tanaka"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Takeshi Morimoto"
                            },
                            {
                                "name": "Reiichi Murakami"
                            },
                            {
                                "name": "Koji Magota"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Coupling factor 6 (CF6), a component of ATP synthase, suppresses the generation of prostacyclin and nitric oxide (NO). Platelet endothelial cell adhesion molecule-1 (PECAM-1) is involved in shear-induced NO production. To investigate the linkage between the actions of CF6 and PECAM-1, we examined the effects of CF6 on PECAM-1 expression and shear-mediated NO release, comparatively with those of angiotensin II (AngII). Treatment of human umbilical vein endothelial cells (HUVEC) and aortic endothelial cells (HAEC) with CF6 at 10(-7) M or AngII at 10(-7) M for 24 h suppressed PECAM-1 gene and protein expression. CF6 or AngII activated c-Src at 15 min in HUVEC, and blockade of c-Src with PP1, its specific inhibitor, restored them. Efrapeptin, an inhibitor of ATPase, attenuated CF6-induced suppression of PECAM-1 gene expression by blockade of acidification, whereas superoxide dismutase or apocinin, an inhibitor of NADPH oxidase, blocked AngII-induced suppression of PECAM-1. Exposure of the cells to shear stress at 25 dynes/cm(2) for 30 min enhanced phosphorylation of eNOS at Ser(1177) and NO release. Pretreatment with CF6 or AngII for 24 h attenuated them in HUVEC and HAEC. These suggest that CF6 downregulates PECAM-1 expression via c-Src activation and attenuates shear-induced NO release presumably by suppressing eNOS phosphorylation. (C) 2007 Elsevier Ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2008-09",
                    "publication_name": {
                        "en": "ATHEROSCLEROSIS"
                    },
                    "volume": "200",
                    "number": "1",
                    "starting_page": "45",
                    "ending_page": "50",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.atherosclerosis.2007.12.010"
                        ],
                        "issn": [
                            "0021-9150"
                        ],
                        "wos_id": [
                            "WOS:000259549800005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.atherosclerosis.2007.12.010",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000259549800005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684106",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684106",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-09T05:34:33Z",
                    "paper_title": {
                        "en": "Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT(1)) receptor: possible role of AT(1) receptor dimerization"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Masahiro Yamada"
                            },
                            {
                                "name": "Motoi Kushibiki"
                            },
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Hirofumi Tomita"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Aims We recently demonstrated that aldosterone induces a non-genomic vasoconstrictor effect on rat coronary arterioles and that this effect was blocked by angiotensin II type 1 receptor (AT(1)) blockers. Intracellular transglutaminase enhances AT(1) signalling by cross-linking AT(1) homodimers. The purpose of this study was to confirm the AT(1)-dependency of the vasoconstrictor effect of aldosterone using AT(1)a knockout (AT(1)aKO) mice and to investigate the role of intracellular transglutaminase and AT(1) dimerization in this effect.\nMethods and results The mesenteric arterioles (60-160 mu m) were isolated from C57BL/6J ( wild-type, WT) and AT1aKO mice, and the internal diameter was measured by video microscopy. Aldosterone (10(-13) to 10(-6) M), but not hydrocortisone, produced a dose-dependent vasoconstriction in WT mice; the maximal diameter change was -8.6 +/- 0.3% from the baseline (P &lt; 0.001). This vasoconstrictor effect was unaffected by the mineralocorticoid receptor antagonist spironolactone or eplerenone, the AT(2) antagonist PD123319, the glucocorticoid receptor antagonist RU486, or endothelium denudation. Aldosterone&apos;s vasoconstrictor effect was negligible in AT(1)aKO mice. The AT(1) blockers valsartan or candesartan suppressed aldosterone-induced vasoconstriction in WT mice. The transglutaminase inhibitors cystamine and monodansyl cadaverine also suppressed the vasoconstrictor effect of aldosterone, without affecting the vasoconstrictor effect of angiotensin II in WT mice. AT(1) dimer protein levels were increased in WT mesenteric arterioles treated with 10(-7) M aldosterone, and the transglutaminase inhibitor and AT(1) blocker blocked this aldosterone-induced formation of AT(1) dimer. Treatment with 10(-7) M aldosterone for 10 min increased the transglutaminase activity by 2.5 +/- 0.2-fold in cultured vascular smooth muscle cells and by 1.2 +/- 0.1-fold in the mesenteric arterioles. These increases were abolished by transglutaminase inhibitors.\nConclusion Aldosterone produces a non-genomic, endothelium-independent vasoconstrictor effect by enhancing intracellular transglutaminase activity and presumably inducing AT(1) dimer formation in mesenteric arterioles."
                    },
                    "publisher": {
                        "en": "OXFORD UNIV PRESS"
                    },
                    "publication_date": "2008-07",
                    "publication_name": {
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "79",
                    "number": "1",
                    "starting_page": "169",
                    "ending_page": "178",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1093/cvr/cvn064"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000257136500022"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1093/cvr/cvn064",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000257136500022&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684104",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684104",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-13T06:35:00Z",
                    "paper_title": {
                        "en": "Therapeutic challenge to adiposity of the heart"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Tomohiro Osanai"
                            },
                            {
                                "name": "Ken Okumura"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2007-04",
                    "publication_name": {
                        "en": "CIRCULATION RESEARCH"
                    },
                    "volume": "100",
                    "number": "8",
                    "starting_page": "1106",
                    "ending_page": "1108",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "others",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1161/01.RES.0000266975.34924.b1"
                        ],
                        "issn": [
                            "0009-7330"
                        ],
                        "wos_id": [
                            "WOS:000246011900003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1161/01.RES.0000266975.34924.b1",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000246011900003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684084",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684084",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "paper_title": {
                        "en": "Therapeutic challenge to adiposity of the heart."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Osanai T"
                            },
                            {
                                "name": "Okumura K"
                            }
                        ]
                    },
                    "publication_date": "2007",
                    "publication_name": {
                        "en": "Cir Res."
                    },
                    "volume": "100",
                    "starting_page": "1106",
                    "ending_page": "1108",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1161/01.RES.0000266975.34924.b1"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1161/01.RES.0000266975.34924.b1",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684103",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684103",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-18T13:09:57Z",
                    "paper_title": {
                        "en": "Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Tanaka"
                            },
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "R Murakami"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "N Maeda"
                            },
                            {
                                "name": "K Satoh"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background Coupling factor 6 (CF6), a component of ATP synthase, inhibits phospholipase A(2) and induces vasoconstriction. However, because arachidonic acid acts in the widespread fields of vascular biology, CF6 might exert profound effects in addition to vasoconstriction. We investigated the effect of CF6 on the gene expression profile in human umbilical vein endothelial cells.\nMethods and results The increased gene expression after 24-h exposure to CF6 at 10(-7) mol/l, assessed by cDNA microarray (n = 3), included neuregulin-1 (1.84 +/- 0.07 fold compared with control, P &lt; 0.05) and relaxin-1 (1.74 +/- 0.20, P &lt; 0.05), both relating to congestive heart failure, urokinase type plasminogen activator receptor (1.77 +/- 0.24, P = 0.06) and estrogen receptor P (1.74 +/- 0.36, P = 0.08), both relating to vascular inflammation and cell infiltration, and protein arginine methyltransferase (PRMT-1; 1.73 +/- 0.20, P &lt; 0.05). Out of these genes, the enzyme relating to the synthesis (PRMT-1) of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), was further examined concomitantly with the degradation enzyme, dimethylarginine dimethylaminohydrolase 2 (DDAH-2). The ratio of PRMT-1 to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA, measured by real-time quantitative reverse transcription-polymerase chain reaction, was increased by 9 +/- 2% (n = 10, P &lt; 0.01) at 48 h after CF6 at 10(-7) mol/l, whereas the ratio of DDAH-2 to GAPDH was decreased by 12 +/- 2% (n = 8, P &lt; 0.01). DDAH-2 protein and activity were decreased by 28 +/- 5% (n = 5, P &lt; 0.01) and 19 2% (n = 6, P &lt; 0.01) by CF6, respectively. ADMA release was enhanced by 20 +/- 8% and NOS activity was decreased by 13 +/- 1% (both n = 8, P &lt; 0.05) by CF6.\nConclusions CF6 changes the gene expression profile to be proatherogenic and functions as a novel stimulator for ADMA release by enhancing its synthesis and suppressing its degradation."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2006-03",
                    "publication_name": {
                        "en": "JOURNAL OF HYPERTENSION"
                    },
                    "volume": "24",
                    "number": "3",
                    "starting_page": "489",
                    "ending_page": "497",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0263-6352"
                        ],
                        "wos_id": [
                            "WOS:000236195400014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000236195400014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684083",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684083",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-18T13:09:57Z",
                    "paper_title": {
                        "en": "Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Tanaka"
                            },
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "R Murakami"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "N Maeda"
                            },
                            {
                                "name": "K Satoh"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background Coupling factor 6 (CF6), a component of ATP synthase, inhibits phospholipase A(2) and induces vasoconstriction. However, because arachidonic acid acts in the widespread fields of vascular biology, CF6 might exert profound effects in addition to vasoconstriction. We investigated the effect of CF6 on the gene expression profile in human umbilical vein endothelial cells.\nMethods and results The increased gene expression after 24-h exposure to CF6 at 10(-7) mol/l, assessed by cDNA microarray (n = 3), included neuregulin-1 (1.84 +/- 0.07 fold compared with control, P &lt; 0.05) and relaxin-1 (1.74 +/- 0.20, P &lt; 0.05), both relating to congestive heart failure, urokinase type plasminogen activator receptor (1.77 +/- 0.24, P = 0.06) and estrogen receptor P (1.74 +/- 0.36, P = 0.08), both relating to vascular inflammation and cell infiltration, and protein arginine methyltransferase (PRMT-1; 1.73 +/- 0.20, P &lt; 0.05). Out of these genes, the enzyme relating to the synthesis (PRMT-1) of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), was further examined concomitantly with the degradation enzyme, dimethylarginine dimethylaminohydrolase 2 (DDAH-2). The ratio of PRMT-1 to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA, measured by real-time quantitative reverse transcription-polymerase chain reaction, was increased by 9 +/- 2% (n = 10, P &lt; 0.01) at 48 h after CF6 at 10(-7) mol/l, whereas the ratio of DDAH-2 to GAPDH was decreased by 12 +/- 2% (n = 8, P &lt; 0.01). DDAH-2 protein and activity were decreased by 28 +/- 5% (n = 5, P &lt; 0.01) and 19 2% (n = 6, P &lt; 0.01) by CF6, respectively. ADMA release was enhanced by 20 +/- 8% and NOS activity was decreased by 13 +/- 1% (both n = 8, P &lt; 0.05) by CF6.\nConclusions CF6 changes the gene expression profile to be proatherogenic and functions as a novel stimulator for ADMA release by enhancing its synthesis and suppressing its degradation."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2006-03",
                    "publication_name": {
                        "en": "JOURNAL OF HYPERTENSION"
                    },
                    "volume": "24",
                    "number": "3",
                    "starting_page": "489",
                    "ending_page": "497",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0263-6352"
                        ],
                        "wos_id": [
                            "WOS:000236195400014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000236195400014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684102",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684102",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T12:37:18Z",
                    "paper_title": {
                        "en": "Intracellular signaling for vasoconstrictor coupling factor 6 - Novel function of beta-subunit of ATP synthase as receptor"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "M Tanaka"
                            },
                            {
                                "name": "M Shimada"
                            },
                            {
                                "name": "R Murakami"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "N Maeda"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Coupling factor 6 (CF6), a component of adenosine triphosphate (ATP) synthase, is circulating and functions as an endogenous vasoconstrictor by inhibiting cytosolic phospholipase A(2). We showed a high plasma level of CF6 in human hypertension. The present study focused on the identification and characterization of a receptor for CF6 and its post-receptor signaling pathway. Incubation of human umbilical vein endothelial cells (HUVECs) with an excess of free CF6 reduced by 50% the immunoreactivity for the antibody to beta-subunit of ATP synthase at the cell surface, but unaffected that for the alpha-subunit antibody. A significant displacement of radioligand was observed at 3 X 10(-9) through 10(-7) M unlabeled CF6, and the Kd was 7.6 nM. Adenosine diphosphate (ADP) at 10-7 M and beta-subunit antibody of I-125-CF6 by 81.3 +/- 9.7% and 32.0 +/- 2.0%, respectively, whereas the alpha-subunit antibody suppressed the binding CF6 by 81.3 9.7% and unaffected it. The hydrolysis activity of ATP to ADP was increased by 1.6-fold by CF6 at 10(-7) M, and efrapeptin at 10(-5), an inhibitor of ATP synthase, blocked it. CF6 at 10(-7) M decreased intracellular pH in 2,7'-bis(carboxyethyl-5 (6))-carboxyfluorescein-loaded HUVEC. Amyloride at 10(-4) M augmented the pH decrease in response to CF6, whereas , efrapeptin at 10(-5) M blocked it. Arachidonic acid release was suppressed by CF6, and it was reversed by efrapeptin at 10(-5) or beta-subunit antibody or ADP at 10(-7) M. The beta-subunit antibody suppressed coupling factor 6-induced increase in blood pressure. These indicate that membrane-bound ATP synthase functions as a receptor for CF6 and may have a previously unsuspected role in the genesis of hypertension by modulating the concentration of intracellular hydrogen."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2005-11",
                    "publication_name": {
                        "en": "HYPERTENSION"
                    },
                    "volume": "46",
                    "number": "5",
                    "starting_page": "1140",
                    "ending_page": "1146",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1161/01.HYP.0000186483.86750.85"
                        ],
                        "issn": [
                            "0194-911X"
                        ],
                        "wos_id": [
                            "WOS:000233544900014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1161/01.HYP.0000186483.86750.85",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000233544900014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684082",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684082",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T12:37:18Z",
                    "paper_title": {
                        "en": "Intracellular signaling for vasoconstrictor coupling factor 6 - Novel function of beta-subunit of ATP synthase as receptor"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "M Tanaka"
                            },
                            {
                                "name": "M Shimada"
                            },
                            {
                                "name": "R Murakami"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "N Maeda"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Coupling factor 6 (CF6), a component of adenosine triphosphate (ATP) synthase, is circulating and functions as an endogenous vasoconstrictor by inhibiting cytosolic phospholipase A(2). We showed a high plasma level of CF6 in human hypertension. The present study focused on the identification and characterization of a receptor for CF6 and its post-receptor signaling pathway. Incubation of human umbilical vein endothelial cells (HUVECs) with an excess of free CF6 reduced by 50% the immunoreactivity for the antibody to beta-subunit of ATP synthase at the cell surface, but unaffected that for the alpha-subunit antibody. A significant displacement of radioligand was observed at 3 X 10(-9) through 10(-7) M unlabeled CF6, and the Kd was 7.6 nM. Adenosine diphosphate (ADP) at 10-7 M and beta-subunit antibody of I-125-CF6 by 81.3 +/- 9.7% and 32.0 +/- 2.0%, respectively, whereas the alpha-subunit antibody suppressed the binding CF6 by 81.3 9.7% and unaffected it. The hydrolysis activity of ATP to ADP was increased by 1.6-fold by CF6 at 10(-7) M, and efrapeptin at 10(-5), an inhibitor of ATP synthase, blocked it. CF6 at 10(-7) M decreased intracellular pH in 2,7'-bis(carboxyethyl-5 (6))-carboxyfluorescein-loaded HUVEC. Amyloride at 10(-4) M augmented the pH decrease in response to CF6, whereas , efrapeptin at 10(-5) M blocked it. Arachidonic acid release was suppressed by CF6, and it was reversed by efrapeptin at 10(-5) or beta-subunit antibody or ADP at 10(-7) M. The beta-subunit antibody suppressed coupling factor 6-induced increase in blood pressure. These indicate that membrane-bound ATP synthase functions as a receptor for CF6 and may have a previously unsuspected role in the genesis of hypertension by modulating the concentration of intracellular hydrogen."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2005-11",
                    "publication_name": {
                        "en": "HYPERTENSION"
                    },
                    "volume": "46",
                    "number": "5",
                    "starting_page": "1140",
                    "ending_page": "1146",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1161/01.HYP.0000186483.86750.85"
                        ],
                        "issn": [
                            "0194-911X"
                        ],
                        "wos_id": [
                            "WOS:000233544900014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1161/01.HYP.0000186483.86750.85",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000233544900014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684101",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684101",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-09T07:16:38Z",
                    "paper_title": {
                        "en": "Troglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibit shear-induced coupling factor 6 release in endothelial cells"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "T Toki"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "N Maeda"
                            },
                            {
                                "name": "R Murakami"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "M Yasujima"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective: We previously showed that mitochondrial coupling factor 6 (CF6), an endogenous inhibitor of prostacyclin synthesis and a vasoconstrictor, is present on the surface of human umbilical vein endothelial cells (HUVEC) and is released outside of the cells by shear stress. We investigated the intracellular signaling mechanism for shear-induced release of CF6 in HUVEC and the effects of troglitazone and 1-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), both peroxisome proliferator-activated receptor (PPAR)-gamma ligands, on it.\nMethods and results: The release and gene expression of CF6 in HUVEC were enhanced by shear stress at 25 dyn/cm(2), measured by radioimmunoassay and real-time RT-PCR, respectively. The intracellular content of CF6 was decreased after exposure to shear stress at 25 dyn/cm(2). Transfection experiments with deletional and mutational CF6 promoter constructs, and with dominant negative mutant IKB kinase a (K44M) demonstrated that shear-induced CF6 transcription was dependent on nuclear factor-kappa B (NF-KB) activation. Pretreatment with troglitazone or 15d-PGJ2 inhibited the shear-induced release and gene expression of CF6, whereas fenofibric acid, a PPAR-alpha ligand, had no influence on them. Western blot and immunostaining showed that troglitazone and 15d-PGJ2 inhibited the shear-induced, reactive oxygen species (ROS)-mediated activation of NF-KB at the level Of IKB protein.\nConclusions: The shear-induced gene expression and release of CF6 in HUVEC are mediated by the ROS-related activation of NF-KB signaling pathway. Troglitazone and 15d-PGJ(2) inhibit them at the IKB protein level. (c) 2005 European Society of Cardiology. Published by Elsevier B.V All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-07",
                    "publication_name": {
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "67",
                    "number": "1",
                    "starting_page": "134",
                    "ending_page": "141",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.cardiores.2005.02.022"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000230194700018"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.cardiores.2005.02.022",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000230194700018&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684081",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684081",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-09T07:16:38Z",
                    "paper_title": {
                        "en": "Troglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibit shear-induced coupling factor 6 release in endothelial cells"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "T Toki"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "N Maeda"
                            },
                            {
                                "name": "R Murakami"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "M Yasujima"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective: We previously showed that mitochondrial coupling factor 6 (CF6), an endogenous inhibitor of prostacyclin synthesis and a vasoconstrictor, is present on the surface of human umbilical vein endothelial cells (HUVEC) and is released outside of the cells by shear stress. We investigated the intracellular signaling mechanism for shear-induced release of CF6 in HUVEC and the effects of troglitazone and 1-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), both peroxisome proliferator-activated receptor (PPAR)-gamma ligands, on it.\nMethods and results: The release and gene expression of CF6 in HUVEC were enhanced by shear stress at 25 dyn/cm(2), measured by radioimmunoassay and real-time RT-PCR, respectively. The intracellular content of CF6 was decreased after exposure to shear stress at 25 dyn/cm(2). Transfection experiments with deletional and mutational CF6 promoter constructs, and with dominant negative mutant IKB kinase a (K44M) demonstrated that shear-induced CF6 transcription was dependent on nuclear factor-kappa B (NF-KB) activation. Pretreatment with troglitazone or 15d-PGJ2 inhibited the shear-induced release and gene expression of CF6, whereas fenofibric acid, a PPAR-alpha ligand, had no influence on them. Western blot and immunostaining showed that troglitazone and 15d-PGJ2 inhibited the shear-induced, reactive oxygen species (ROS)-mediated activation of NF-KB at the level Of IKB protein.\nConclusions: The shear-induced gene expression and release of CF6 in HUVEC are mediated by the ROS-related activation of NF-KB signaling pathway. Troglitazone and 15d-PGJ(2) inhibit them at the IKB protein level. (c) 2005 European Society of Cardiology. Published by Elsevier B.V All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-07",
                    "publication_name": {
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "67",
                    "number": "1",
                    "starting_page": "134",
                    "ending_page": "141",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.cardiores.2005.02.022"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000230194700018"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.cardiores.2005.02.022",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000230194700018&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684100",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684100",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-26T14:17:52Z",
                    "paper_title": {
                        "ja": "Tumor necrosis factor  as an endogenous stimulator for circulating coupling factor 6.",
                        "en": "Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "Sasaki S"
                            },
                            {
                                "name": "Osanai T"
                            },
                            {
                                "name": "Tomita H"
                            },
                            {
                                "name": "Matsunaga T"
                            },
                            {
                                "name": "Magota K"
                            },
                            {
                                "name": "Okumura K"
                            }
                        ],
                        "en": [
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "T Matsunaga"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective: We recently showed that mitochondrial coupling factor 6 (CF6) is present as a pressor substance and a prostacyclin inhibitor in systemic circulation. However, the regulation mechanism for circulating CF6 is unknown. We investigated the role of tumor necrosis factor-alpha (TNF-alpha) in the generation and release of CF6. Methods and results: We used two kinds of cells, human umbilical vein endothelial cells (HUVEC) and ECV-304. The concentration of CF6 in the medium increased with time in both ECV-304 and HUVEC. Treatment of ECV-304 and HUVEC with TNF-a enhanced the release of CF6 in a dose-dependent manner concomitantly with the decrease in CF6 content in the mitochondria at 24 h. The released CF6 was characterized to be an active full-length peptide by Western blot. The ratio of CF6 to GAPDH mRNA, measured by real-time polymerase chain reaction, was 1.7 fold increased at 1 h after exposure to TNF-alpha in ECV-304 and HUVEC. This enhanced gene expression and release was blocked or suppressed by 70% by stable transfection of dominant negative mutant IkappaB kinase alpha whose efficacy was confirmed by blockade of translocation of NF-kappaB p65 protein and of degradation Of IkappaBalpha protein. Flow cytometry analysis revealed that the cell surface-associated CF6 was significantly increased at 24 h after TNF-alpha in a dose-dependent manner. Conclusions: TNF-alpha stimulates the gene expression of CF6 via activation of NF-kappaB signaling pathway, and promotes the release of CF6 from ECV-304 and HUVEC. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2004-06",
                    "publication_name": {
                        "ja": "Cardiovasc Res",
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "62",
                    "number": "3",
                    "starting_page": "578",
                    "ending_page": "586",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.cardiores.2004.01.031"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000221924300018"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.cardiores.2004.01.031",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000221924300018&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684080",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684080",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-26T14:17:52Z",
                    "paper_title": {
                        "en": "Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "T Matsunaga"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective: We recently showed that mitochondrial coupling factor 6 (CF6) is present as a pressor substance and a prostacyclin inhibitor in systemic circulation. However, the regulation mechanism for circulating CF6 is unknown. We investigated the role of tumor necrosis factor-alpha (TNF-alpha) in the generation and release of CF6. Methods and results: We used two kinds of cells, human umbilical vein endothelial cells (HUVEC) and ECV-304. The concentration of CF6 in the medium increased with time in both ECV-304 and HUVEC. Treatment of ECV-304 and HUVEC with TNF-a enhanced the release of CF6 in a dose-dependent manner concomitantly with the decrease in CF6 content in the mitochondria at 24 h. The released CF6 was characterized to be an active full-length peptide by Western blot. The ratio of CF6 to GAPDH mRNA, measured by real-time polymerase chain reaction, was 1.7 fold increased at 1 h after exposure to TNF-alpha in ECV-304 and HUVEC. This enhanced gene expression and release was blocked or suppressed by 70% by stable transfection of dominant negative mutant IkappaB kinase alpha whose efficacy was confirmed by blockade of translocation of NF-kappaB p65 protein and of degradation Of IkappaBalpha protein. Flow cytometry analysis revealed that the cell surface-associated CF6 was significantly increased at 24 h after TNF-alpha in a dose-dependent manner. Conclusions: TNF-alpha stimulates the gene expression of CF6 via activation of NF-kappaB signaling pathway, and promotes the release of CF6 from ECV-304 and HUVEC. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2004-06",
                    "publication_name": {
                        "en": "CARDIOVASCULAR RESEARCH"
                    },
                    "volume": "62",
                    "number": "3",
                    "starting_page": "578",
                    "ending_page": "586",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.cardiores.2004.01.031"
                        ],
                        "issn": [
                            "0008-6363"
                        ],
                        "wos_id": [
                            "WOS:000221924300018"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.cardiores.2004.01.031",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000221924300018&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684098",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684098",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-29T06:17:48Z",
                    "paper_title": {
                        "en": "Circulating coupling factor 6 in human hypertension: role of reactive oxygen species"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "T Kamada"
                            },
                            {
                                "name": "N Fujiwara"
                            },
                            {
                                "name": "T Nakano"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "T Matsunaga"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective Coupling factor 6 is an endogenous inhibitor of prostacyclin synthesis and might function as an endogenous vasoconstrictor in the fashion of a circulating hormone in rats. We investigated the role of coupling factor 6 in human hypertension.\nMethods and results The patients with essential hypertension (EH) (n = 30) received a series of normal salt diet (112 g salt/day) for 3 days, low salt diet (2 g salt/day) for 7 days, and high salt diet (20-23 g salt/day) for 7 days. Normotensive control subjects (n = 27) received normal and low salt diets. The plasma level of coupling factor 6, measured by radioimmunoassay, during normal salt diet was higher in patients with EH than in normotensive subjects (17.6 +/- 1.7 versus 12.8 +/- 0.5 ng/ml, P &lt; 0.01). Whereas the plasma level of coupling factor 6 was unchanged after salt restriction in normotensive subjects, it was decreased after salt restriction (from 12 g/day to 2 g/day) and was increased after salt loading (from 2 g/day to 20-23 g/day) in patients with EH. This increase in plasma level of coupling factor 6 was abolished by oral administration of ascorbic acid, but the level of blood pressure was unaffected. The percentage changes in plasma coupling factor 6 level after salt restriction and loading were positively correlated with those in mean blood pressure (r = 0.57, P &lt; 0.01), and negatively correlated with those in plasma nitric oxide level (r = -0.51, P &lt; 0.05).\nConclusion These indicate that circulating coupling factor 6 is elevated in human hypertension and modulated by salt intake presumably via reactive oxygen species. (c) 2003 Lippincott Williams C Wilkins."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2003-12",
                    "publication_name": {
                        "en": "JOURNAL OF HYPERTENSION"
                    },
                    "volume": "21",
                    "number": "12",
                    "starting_page": "2323",
                    "ending_page": "2328",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1097/01.hjh.0000098161.70956.08"
                        ],
                        "issn": [
                            "0263-6352"
                        ],
                        "wos_id": [
                            "WOS:000228083000020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1097/01.hjh.0000098161.70956.08",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000228083000020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684097",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684097",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-28T21:21:57Z",
                    "paper_title": {
                        "en": "Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "M Nakamura"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "M Saitoh"
                            },
                            {
                                "name": "H Osawa"
                            },
                            {
                                "name": "H Yamabe"
                            },
                            {
                                "name": "S Murakami"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background. Plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), is an independent predictor of overall mortality and cardiovascular outcome in hemodialysis patients. However, not only ADMA but also traditional risk factors account for only part of the high cardiovascular morbidity and mortality in these patients. We investigated cross-sectionally the association between coupling factor 6 (CF6), an endogenous inhibitor of prostacyclin synthesis, and cardiovascular events in 95 hemodialysis patients.\nMethods. Plasma CF6 level was measured by radioimmunoassay, whereas plasma ADMA level by high-performance liquid chromatography (HPLC).\nResults. Plasma levels of CF6 and ADMA were threefold higher in hemodialysis patients than in control individuals, and there was a positive correlation between these two compounds (r = 0.25, P &lt; 0.05). Plasma CF6 level was positively correlated with serum creatinine level (r = 0.36, P &lt; 0.01) and was reduced after dialysis (P &lt; 0.05). Plasma CF6 and ADMA levels were both higher in hemodialysis patients complicating ischemic heart disease (myocardial infarction and/or angina) than in those free of cardiovascular events. In a multiple regression model, plasma CF6 level (r = 0.24, P = 0.023) and ADMA level (r = 0.26, P = 0.023) were independently related to the occurrence of ischemic heart disease in hemodialysis patients.\nConclusion. CF6 is a novel risk factor for ischemic heart disease in end-stage renal disease (ESRD). Synergism of this peptide and ADMA might contribute to its occurrence presumably by inhibition of prostacyclin and nitric oxide production."
                    },
                    "publisher": {
                        "en": "BLACKWELL PUBLISHING INC"
                    },
                    "publication_date": "2003-12",
                    "publication_name": {
                        "en": "KIDNEY INTERNATIONAL"
                    },
                    "volume": "64",
                    "number": "6",
                    "starting_page": "2291",
                    "ending_page": "2297",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1046/j.1523-1755.2003.00334.x"
                        ],
                        "issn": [
                            "0085-2538"
                        ],
                        "wos_id": [
                            "WOS:000186431600038"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1046/j.1523-1755.2003.00334.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000186431600038&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/misc/3684079",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0167650/misc",
                    "rm:id": "3684079",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-29T06:17:48Z",
                    "paper_title": {
                        "en": "Circulating coupling factor 6 in human hypertension: role of reactive oxygen species"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Osanai"
                            },
                            {
                                "name": "S Sasaki"
                            },
                            {
                                "name": "T Kamada"
                            },
                            {
                                "name": "N Fujiwara"
                            },
                            {
                                "name": "T Nakano"
                            },
                            {
                                "name": "H Tomita"
                            },
                            {
                                "name": "T Matsunaga"
                            },
                            {
                                "name": "K Magota"
                            },
                            {
                                "name": "K Okumura"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective Coupling factor 6 is an endogenous inhibitor of prostacyclin synthesis and might function as an endogenous vasoconstrictor in the fashion of a circulating hormone in rats. We investigated the role of coupling factor 6 in human hypertension.\nMethods and results The patients with essential hypertension (EH) (n = 30) received a series of normal salt diet (112 g salt/day) for 3 days, low salt diet (2 g salt/day) for 7 days, and high salt diet (20-23 g salt/day) for 7 days. Normotensive control subjects (n = 27) received normal and low salt diets. The plasma level of coupling factor 6, measured by radioimmunoassay, during normal salt diet was higher in patients with EH than in normotensive subjects (17.6 +/- 1.7 versus 12.8 +/- 0.5 ng/ml, P &lt; 0.01). Whereas the plasma level of coupling factor 6 was unchanged after salt restriction in normotensive subjects, it was decreased after salt restriction (from 12 g/day to 2 g/day) and was increased after salt loading (from 2 g/day to 20-23 g/day) in patients with EH. This increase in plasma level of coupling factor 6 was abolished by oral administration of ascorbic acid, but the level of blood pressure was unaffected. The percentage changes in plasma coupling factor 6 level after salt restriction and loading were positively correlated with those in mean blood pressure (r = 0.57, P &lt; 0.01), and negatively correlated with those in plasma nitric oxide level (r = -0.51, P &lt; 0.05).\nConclusion These indicate that circulating coupling factor 6 is elevated in human hypertension and modulated by salt intake presumably via reactive oxygen species. (c) 2003 Lippincott Williams C Wilkins."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2003-12",
                    "publication_name": {
                        "en": "JOURNAL OF HYPERTENSION"
                    },
                    "volume": "21",
                    "number": "12",
                    "starting_page": "2323",
                    "ending_page": "2328",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1097/01.hjh.0000098161.70956.08"
                        ],
                        "issn": [
                            "0263-6352"
                        ],
                        "wos_id": [
                            "WOS:000228083000020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1097/01.hjh.0000098161.70956.08",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000228083000020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0167650/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0167650",
            "total_items": 7,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616657",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616657",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本循環器管理研究協議会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616656",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616656",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本腎臓学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616655",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616655",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本老年病学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616654",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616654",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本動脈硬化学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616653",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616653",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本循環器学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616652",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616652",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本高血圧学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/association_memberships/616651",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0167650/association_memberships",
                    "rm:id": "616651",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本内科学会"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0167650/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0167650",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_projects/747320",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_projects",
                    "rm:id": "747320",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "research_project_title": {
                        "ja": "新規の昇圧物質カップリングファクター６の病態生理的意義"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "description": {
                        "ja": "我々は、新規の昇圧物質coupling factor 6 (CF6)を発見した。CF6は血管内皮細胞に作用し、細胞内酸性化を介して、PGI2,NO,EETの産生を阻害し、動脈硬化の発症進展に深く関与する。現在、遺伝子改変マウスを作製し、そのphenotypeのついて研究を進めている。"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_projects/747319",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_projects",
                    "rm:id": "747319",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "research_project_title": {
                        "ja": "冠れん縮性狭心症の病態に関する研究"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "description": {
                        "ja": "冠攣縮性狭心症患者から、PLC-delta1の遺伝子異常を発見した。さらにPLC-delta1の活性化因子P122の発現亢進を明らかにした。PLC-deta1はカルシウムで活性化され、細胞内のカルシウムを上昇させ過収縮を引き起こす。現在、遺伝子改変マウスを作製し、冠攣縮のvivoにおける証明を行っている。"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_projects/747318",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_projects",
                    "rm:id": "747318",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "research_project_title": {
                        "en": "Pathophysiological role of novel vasoconstrictor peptide, coupling factor 6, in cardiovascular diseases"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0167650/research_projects/747317",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0167650/research_projects",
                    "rm:id": "747317",
                    "rm:user_id": "1000003035",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000003035",
                    "rm:creator_type": "myself",
                    "rm:created": "2009-03-09T15:00:00Z",
                    "rm:modifier_id": "1000003035",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2009-03-09T15:00:00Z",
                    "research_project_title": {
                        "en": "Study on the mechanism for vasospastic angina"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        }
    ]
}